Total VTE | Newly developed VTE | |||||
---|---|---|---|---|---|---|
Variable | OR | (95% CI) | P | OR | (95% CI) | P |
Elderly femalea | 3.3 | (0.9–12.4) | 0.066 | - | ||
BMI ≥25b | - | 2.5 | (0.5–12.0) | 0.25 | ||
Reduced mobilityc | 4.9 | (1.0–24.9) | 0.057 | - | ||
6–12 months from tumor onsetd | - | 3.0 | (0.6–15.8) | 0.19 | ||
Increased TATe | 2.4 | (0.9–6.4)f | 0.092 | 3.8 | (0.7–20.8)g | 0.12 |
Non-increased PICh | 1.2 | (0.3–4.0) | 0.78 | - | ||
Increased TATe and non-increased PICh | 3.0 | (1.1–8.2)i | 0.034* | 9.4 | (1.7–51.9)j | 0.011* |